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Lactobacillus species are nonspore-forming, strictly
anaerobic or facultative, and Gram-positive bacilli that
normally colonize in the oral cavity, gastrointestinal tract
and female genital tract. These bacteria may cause serious
infections or severe comorbidities in immunocompromised
hosts.1 Most infections occur as bacteremia, endocarditis,
or pneumonia.1 Lactobacillus casei and Lactobacillus
rhamnosus are the most common causative species, and
Lactobacillus salivarius infection is rather rare.1 We report
a case with diabetic ketoacidosis (DKA) due to L. salivarius
infection accompanied by bacteremia, empyema and res-
piratory failure.
A 56-year-old man visited the emergency room from
Northern Taiwan with a history of alcoholism and diabetes
mellitus. He had previously undergone subtotal gastrec-
tomy. He had a week of fever and general malaise. Before
admission, the patient was drunk and vomiting. On arrival,
he was responsive, with sinus tachycardia and decreased
breathing sounds over his right chest. He had a raised
white blood count with neutrophilia. The biochemistry
findings showed blood sugar (555 mg/dL), C-reactive
protein (7.05 mg/L), ketonuria (3þ), and blood ketones.
Arterial blood gas indicated a metabolic acidosis
( pH 7.378, PaCO2 17.0, PO2 74.8, HCO3 9.8 and base
excess e12.8).
An initial chest x-ray showed moderate right pleural
effusion. Chest computed tomography revealed right
loculated pleural effusion and air-fluid collection
(Figure 1). Pus-like fluid was aspirated from the right
chest cavity, and a chest tube was inserted for drainage.
He developed septic shock, needing ventilator support.
Pleural effusion indicated the presence of Gram-positive
bacilli. He was diagnosed with DKA secondary to empy-
ema and started on intravenous insulin, fluids and anti-
biotics. Clindamycin and ceftriaxone were administeredPlease cite this article in press as: Wang H-K, et al., Lactobacillus sali
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showed right pulmonary consolidation with extensive
and loculated pleural effusions (Figure 2). The antimi-
crobial agents were changed to imipenem. Fibrinolytic
therapy with urokinase was administrated through the
right chest tube, and the organized effusion resolved.
We checked for a possible esophagopleural fistula using
an esophagogram and for a subphrenic abscess using an
abdominal computed tomography scan, and these were
both negative. The patient was discharged after 21 days
of imipenem treatment and remained in good health
after discharge. HIV test remained negative at a follow-
up 6 months later. The organisms from the pleural
effusion and two blood samples were identified as
Lactobacillus acidophillus, with a similarity of 99%, using
the bioMe´rieux VITEK (bioMe´rieux, Hazelwood, USA)
anaerobic identification system. The isolate was sus-
ceptible to penicillin, amoxicillin/clavunate, clindamy-
cin, and imipenem, but resistant to ceftazidime,
vancomycin, and teicoplanin, as determined by the
Etest. We used 16S rRNA gene amplification and
sequencing, which showed it to be 100% identical with
that of L salivarius.
Pleural empyema is a serious condition whose inci-
dence is rising worldwide.2 The most common pathogens
responsible for empyema are Streptococcus, Staphylo-
coccus, anaerobes and Enterobacteriaceae.2,3 Lactoba-
cillus empyema is rather rare. A search of the English
literature identified another three cases of Lactobacillus
empyema thoracis (Table 1). All of the four patients
received thoracostomy tube placement and survived. The
mortality rate from pleural empyema ranges from 15% to
50% depending on the population.2,3 According to a
scoring system for bacteremia presenting to the emer-
gent department, our patient was stratified as high
mortality rate to over 50%.4 Our patient initially
responded poorly to the empiric treatment after 7 daysvarius empyema with respiratory failure, Journal of Microbiology,
16.06.001
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Figure 2. Progressive ill-defined air-space consolidation in
the right lower lung and left hilar infiltration after 8th day of
chest tube drainage. R Z Right.
Table 1 Up-to date review of the English-language publication
Author/
Reference
Age/
gender
Comorbidities Specimen
Present case 56/Male DM
DKA
Blood culture,
pleural effusion
Shoji et al 5 79/Male d BAL,
pleural effusion
Luong
et al 6
56/
Male
IPF with double lung
transplantation, HIV
infection
Pleural effusion
Stephen
et al 7
52/
Male
Single lung
transplantation, COPD
Pleural effusion
BAL
BALZ bronchioalvelar lavage; COPDZ chronic obstructive pulmonar
HIVZ human immunodeficiency virus; IPFZ idiopathic pulmonary fib
Figure 1. Empyema on admission. Contrast computed to-
mography showing loculated right pleural effusion and air-fluid
collection (arrows). PZ Posterior; R Z Right.
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Lactobacillus species, we shifted to imepenem treatment
because Lactobacillus infection is common during poly-
microbial infections.1 The other reason was that Lacto-
bacillus isolates tended to be sensitive to clindamycin
and imipenem and resistant to vancomycin and ceftazi-
dime.1 L. salivarius is resistant to acidic conditions and it
also produces lactic acid that has bacteriocidal or
bacteriostatic effects on other bacteria. This inhibition
of other bacteria may explain why this patient with DKA
and pleural effusion/blood culture recovered for this
single species.
For the initial empyema treatment, most physicians
prescribed empirical antimicrobial agents according to
the Gram-positive bacilli stain from the pleural effusion.
Anaerobic, nonsporulating, and Gram-positive bacilli,
including Actinomycetes, Eubacterium, Eggerthella,
Propionibacterium, and Bifidobacterium may also be
responsible and treatments are different. Accurate
identification to the genus level of Gram-positive bacilli
is usually not available in clinical laboratories, but such
identification is important so that physicians can pre-
scribe appropriate antibiotics for critical patients. The
results of our VITEK (bioMe´rieux) system for the identi-
fication of anaerobic organisms initially described the
species as L. acidophilus. Commercial test kits are
not reliable for species identification of Lactobacilli.
Thus, our initial misidentification of species was not
unusual.
In up to 40% of cases with empyema, a microbiological
diagnosis is not possible by standard techniques.3 Use of
nucleic acid amplification targeting 16S ribosomal DNA for
pleural effusion provides increased microbiological yields
up to 75%.3
An appropriate antibiotic regimen can be used to suc-
cessfully treat the growing problem of empyema, and gene
sequencing can be used for rapid identification of nonspore-
forming Gram-positive bacilli. Proper identification is
especially important in the treatment of pleural empyema,
which has a high fatality rate.s on Lactobacillus species empyema
Disease Species Treatment Outcome
Empyema L. salivarius Imipenem Survived
Lung abscess,
Empyema
L. rhamnosus Clindamycinþ
Meropenem
Survived
Empyema L. rhamnosus Ampicillinþ
Sulbactam
Survived
, Empyema Lactobacillus
species
Ceftazidime,
Clindamycin
Survived
y disease; DKAZ diabetic ketoacidosis; DMZ diabetes mellitus;
rosis.
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